ExodusPoint Capital Management »

Lyra Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $41k 159k 0.26
2024-03-31 $200k 32k 6.23
2021-06-30 $253k 32k 8.02
2020-06-30 $947k 84k 11.34

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Johnson & Johnson Put Option (JNJ)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
NiSource (NI)
CMS Energy Corporation (CMS)
PPL Corporation (PPL)
Tesla Motors Put Option (TSLA)
Mondelez Intl Cl A (MDLZ)
Becton, Dickinson and (BDX)
Exelon Corporation (EXC)

View all positions for ExodusPoint Capital Management

Top funds holding Lyra Therapeutics

Perceptive Advisors
Citadel Advisors
BlackRock
BlackRock
Samsara BioCapital
Vanguard Group
Ikarian Capital
Sei Investments
Morgan Stanley
Geode Capital Management
Two Sigma Advisers
Two Sigma Investments
State Street Corporation
Everhart Financial Group
Northern Trust

View all funds holding Lyra Therapeutics